Have a personal or library account? Click to login
Allergic Acute Coronary Syndrome Without Identifiable Triggers – Kounis Syndrome Type I Associated with Chronic Spontaneous Urticaria. Case Report and Review of the Literature Cover

Allergic Acute Coronary Syndrome Without Identifiable Triggers – Kounis Syndrome Type I Associated with Chronic Spontaneous Urticaria. Case Report and Review of the Literature

Open Access
|Sep 2025

References

  1. Kounis NG, Grapsas ND, Goudevenos JA. Unstable angina, allergic angina, and allergic myocardial infarction. Circulation. 1999;100(25). doi: 10.1161/01.CIR.100.25.e156
  2. Liu Y, Lu C, Guo Q. Recurrent Type III Kounis Syndrome: Will Anti–Immunoglobulin E Drug Be Another Option? Canadian Journal of Cardiology. 2020;36(6):966.e5–966.e6. doi: 10.1016/j.cjca.2019.12.007
  3. Kounis NG, Koniari I, Velissaris D, Tzanis G, Hahalis G. Kounis syndrome-not a single-organ arterial disorder but a multisystem and multidisciplinary disease. Balkan Med J. 2019;36(4):212–221. doi: 10.4274/balkanmedj.galenos.2019.2019.5.62
  4. Macías E, Amador E, Sandia A, Taracena S. Allergic angina syndrome, allergic myocardial infarct or Kounis syndrome: insights on epidemiology, etiology, diagnosis and treatment. A case report by gadolinium anaphylaxis. Arch Cardiol Mex. 2024;94(4):495–501. doi: 10.24875/ACM.23000187
  5. Zisa G, Panero A, Re A, Mennuni MG, Patti G, Pirisi M. Kounis syndrome: an underestimated emergency. Eur Ann Allergy Clin Immunol. 2023;55(6):294–302. doi: 10.23822/EurAnnACI.1764-1489.260
  6. Biteker M, Biteker FS, Özlek B, Özlek E, Başaran N. Classification of Kounis syndrome. Int J Cardiol. 2017;247:13. doi: 10.1016/j.ijcard.2017.06.002
  7. Masuda M, Fujimoto W, Yamashita S, et al. Recurrent cardiac arrests caused by Kounis syndrome without typical allergic symptoms. J Cardiol Cases. 2023;27(2):47–51. doi: 10.1016/j.jccase.2022.10.004
  8. Akbaş İ, Kocak AO, Doğruyol S. Kounis Syndrome That Recurs in A Short Time Period: A Case Report. Journal of Emergency Medicine Case Reports. 2023;13(4):107–110. doi: 10.33706/jemcr.1126723
  9. Benchea LC, Anghel L, Scripcariu DV, et al. Kounis Syndrome in Clinical Practice: Insights from Clinical Case Series and Mechanistic Pathways. J Clin Med. 2025;14(3). doi: 10.3390/jcm14030768
  10. Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720–3826. doi: 10.1093/eurheartj/ehad191
  11. Fatade YA, Newman NA, Patel NH, Mehta PK. MI and Non-obstructive Coronary Arteries. US Cardiology Review. 2024;18. doi: 10.15420/usc.2023.12
  12. Sucato V, Comparato F, Ortello A, Galassi AR. Myocardical infarction with non-obstructive coronary arteries (MINOCA): Phatogenesis, diagnosis and treatment. Curr Probl Cardiol. 2024;49(7). doi: 10.1016/j.cpcardiol.2024.102583
  13. Trimarchi G, Teresi L, Licordari R, et al. Transient Left Ventricular Dysfunction from Cardiomyopathies to Myocardial Viability: When and Why Cardiac Function Recovers. Biomedicines. 2024;12(5). doi: 10.3390/biomedicines12051051
  14. Kounis NG. Kounis syndrome (allergic angina and allergic myocardial infarction): A natural paradigm? Int J Cardiol. 2006;110(1):7–14. doi: 10.1016/j.ijcard.2005.08.007
  15. Gulen T, Akin C. Idiopathic Anaphylaxis: a Perplexing Diagnostic Challenge for Allergists. Curr Allergy Asthma Rep. 2021 Feb 9;21(2):11. doi: 10.1007/s11882-021-00988-y
  16. Sandhu M, Casselman J, Peppers B, Tcheurekdjian H, Hostoffer RW. Type 1 Kounis Syndrome in a Patient with Idiopathic Anaphylaxis. Allergy and Rhinology. 2017;8(2). doi: 10.2500/ar.2017.8.0198
  17. Keber T, Makuc J, Sekavčnik G. Type 1 Kounis Syndrome in Patient with Idiopathic Anaphylaxis. Case Rep Cardiol. 2017;2017:1–3. doi: 10.1155/2017/1089023
  18. Biteker M. Current understanding of Kounis syndrome. Expert Rev Clin Immunol. 2010;6(5):777–788. doi: 10.1586/eci.10.47
  19. Brancaccio R, Bonzano L, Cocconcelli A, Boyko R, Ienopoli G, Motolese A. Recurrent Kounis Syndrome: A Case Report and Literature Review. J Clin Med. 2024;13(6). doi: 10.3390/jcm13061647
  20. Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy: European Journal of Allergy and Clinical Immunology. 2018;73(7):1393–1414. doi: 10.1111/all.13397
  21. Kolkhir P, Church MK, Weller K, Metz M, Schmetzer O, Maurer M. Autoimmune chronic spontaneous urticaria: What we know and what we do not know. Journal of Allergy and Clinical Immunology. 2017;139(6):1772–1781.e1. doi: 10.1016/j.jaci.2016.08.050
  22. Erxun K, Wei L, Shuying Q. Kounis Syndrome Caused by Chronic Autoimmune Urticaria: A Case Report. Journal of Emergency Medicine. 2016;50(1):37–40. doi: 10.1016/j.jemermed.2015.01.036
  23. Maurer M, Khan DA, Elieh Ali Komi D, Kaplan AP. Biologics for the Use in Chronic Spontaneous Urticaria: When and Which. Journal of Allergy and Clinical Immunology: In Practice. 2021;9(3):1067–1078. doi: 10.1016/j.jaip.2020.11.043
  24. Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy: European Journal of Allergy and Clinical Immunology. 2022;77(3):734–766. doi: 10.1111/all.15090
  25. Kaplan A, Ferrer M, Bernstein JA, et al. Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria. Journal of Allergy and Clinical Immunology. 2016;137(2):474–481. doi: 10.1016/j.jaci.2015.08.023
  26. Godse K, Rajagopalan M, Girdhar M, Kandhari S, Shah B, Chhajed PN, Tahiliani S, Shankar DS, Somani V, Zawar V. Position statement for the use of omalizumab in the management of chronic spontaneous urticaria in Indian patients. Indian Dermatol Online J. 2016;7(1):6–11. doi: 10.4103/2229-5178.174314
  27. Kazama I. Anti-vasospastic mast cell stabilizers: a novel therapeutic approach to anaphylaxis-induced acute coronary syndrome. Clin Exp Vaccine Res. 2025;14(2):185–188. doi: 10.7774/cevr.2025.14.e16
  28. Zhao C, Lei R, Liu S, Zhao M. Kounis syndrome following COVID-19 vaccination: Clinical manifestations, mechanisms and management. Hum Vaccin Immunother. 2024;20(1). doi: 10.1080/21645515.2024.2365496
  29. Allam C, Kounis NG, Chlawit R, Saouma M, Badaoui G. Kounis syndrome following COVID-19 vaccination. Baylor University Medical Center Proceedings. 2022;35(3):369–370. doi: 10.1080/08998280.2022.2034226
  30. Kounis NG, Gogos C, de Gregorio C, et al. “When,” “Where,” and “How” of SARS-CoV-2 Infection Affects the Human Cardiovascular System: A Narrative Review. Balkan Med J. 2024;41(1):7–22. doi: 10.4274/balkanmedj.galenos.2023.2023-10-25
  31. Helberg J, Acosta E. Kounis Syndrome as a Cause of Myocardial Infarction with Nonobstructive Coronary Arteries. Kans J Med. 2024;17(2):34–35. doi: 10.17161/kjm.vol17.21486
  32. Tamis-Holland JE, Jneid H, Reynolds HR, et al. Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association. Circulation. 2019;139(18):E891–E908. doi: 10.1161/CIR.0000000000000670
DOI: https://doi.org/10.2478/jce-2025-0016 | Journal eISSN: 2457-5518 | Journal ISSN: 2457-550X
Language: English
Page range: 99 - 105
Submitted on: Jul 25, 2025
|
Accepted on: Aug 27, 2025
|
Published on: Sep 23, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Maria Andreea Micu, Dan Alexandru Cozac, Diana Ioana Prația-Aron, Cosmin Macarie, Corina Ureche, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.